{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:42:09Z","timestamp":1787010129330,"version":"build-2736575974"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Science &amp;Technology Department Program of Sichuan Province","award":["2019YFS0338"],"award-info":[{"award-number":["2019YFS0338"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Adjuvant endocrine therapy is a vital portion of postoperative comprehensive treatment for breast cancer patients. In recent years, studies have shown that endocrine therapy has a certain impact on the serum lipids of breast cancer patients, and the changes of lipid profiles may bring a series of problems. However, very few studies focus on this issue to date. The results of these studies are inconsistent, and the influence of different adjuvant endocrine modalities on lipid profiles still remains controversial. In order to better explore this issue, we conduct this network meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method:<\/jats:title>\n                    <jats:p>The protocol followed preferred reporting items for systematic reviews and meta-analyses protocols. Three main databases (PubMed, Embase, and the Cochrane Library) will be searched systematically for eligible randomized controlled trials without language restriction. In addition, a manual search of the references of relevant published studies will also be considered. Two reviewers will conduct studies selection, data extraction, and risk of bias assessment independently. The primary outcome is the variation of biochemical parameters \u2013 the serum lipid profiles (cholesterol, triglyceride, high-density lipoprotein, low low-density lipoprotein).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The results will provide useful information about the side effects of different adjuvant endocrine drugs on lipid profiles in postoperative breast cancer patients (estrogen receptor-positive and\/or progesterone receptor-positive).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The findings of this study will be published in a peer-reviewed journal.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Prospero Registration Number:<\/jats:title>\n                    <jats:p>CRD42019129850.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000018550","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T12:33:41Z","timestamp":1578486821000},"page":"e18550","source":"Crossref","is-referenced-by-count":14,"title":["Comparative effectiveness of tamoxifen, toremifene, letrozole, anastrozole, and exemestane on lipid profiles in breast cancer patients"],"prefix":"10.1097","volume":"99","author":[{"given":"Tao","family":"He","sequence":"first","affiliation":[{"name":"Department of Breast Surgery, West China Hospital\/West China School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, West China Second Hospital\/West China School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Zhang","sequence":"additional","affiliation":[{"name":"West China School of Medicine, Sichuan University, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[{"name":"West China School of Medicine, Sichuan University, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Yang","sequence":"additional","affiliation":[{"name":"West China School of Medicine, Sichuan University, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhao","family":"Wu","sequence":"additional","affiliation":[{"name":"West China School of Medicine, Sichuan University, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, West China Hospital\/West China School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengya","family":"Xiang","sequence":"additional","affiliation":[{"name":"West China School of Medicine, Sichuan University, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Huang","sequence":"additional","affiliation":[{"name":"West China School of Medicine, Sichuan University, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[{"name":"West China School of Medicine, Sichuan University, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runke","family":"Zhou","sequence":"additional","affiliation":[{"name":"West China School of Medicine, Sichuan University, Chengdu, Sichuan, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Lv","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, West China Hospital\/West China School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, West China Hospital\/West China School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,1]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R2-20230915","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10549-012-2176-4","article-title":"Impact of comorbidity on management and mortality in women diagnosed with breast cancer","volume":"135","author":"Berglund","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.7314\/APJCP.2015.16.14.6081","article-title":"Incidence and mortality of breast cancer and their relationship to development in Asia","volume":"16","author":"Ghoncheh","year":"2015","journal-title":"Asian Pac J Cancer Prev"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10549-014-3021-8","article-title":"Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study","volume":"146","author":"Jordan","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"R5-20230915","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10549-017-4295-4","article-title":"Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis","volume":"165","author":"Edwards","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.breast.2017.05.014","article-title":"Palliative systemic therapy and overall survival of 1,395 patients with advanced breast cancer \u2013 results from the prospective German TMK cohort study","volume":"34","author":"Fietz","year":"2017","journal-title":"Breast"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10549-016-3960-3","article-title":"The relationship between time to initiation of adjuvant chemotherapy and survival in breast cancer: a systematic review and meta-analysis","volume":"160","author":"Raphael","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00280-017-3491-6","article-title":"Serum lipid and bone metabolism effects of Toremifene vs. Letrozole as adjuvant therapy for postmenopausal early breast cancer patients: results of a multicenter open randomized study","volume":"81","author":"Shien","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejca.2017.05.002","article-title":"Different patterns in the risk of newly developed fatty liver and lipid changes with tamoxifen versus aromatase inhibitors in postmenopausal women with early breast cancer: a propensity score\u2013matched cohort study","volume":"82","author":"Hong","year":"2017","journal-title":"Eur J Cancer"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1158\/1078-0432.CCR-15-1213","article-title":"Association of variants in candidate genes with lipid profiles in women with early breast cancer on adjuvant aromatase inhibitor therapy","volume":"22","author":"Santa-Maria","year":"2016","journal-title":"Clin Cancer Res"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10549-012-2294-z","article-title":"Lipid concentrations in postmenopausal women on letrozole after 5 years of tamoxifen: an NCIC CTG MA.17 sub-study","volume":"136","author":"Wasan","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1177\/0091270011424153","article-title":"Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozole","volume":"52","author":"Bell","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/cpdd.420","article-title":"Comparison of changes in the lipid profiles of eastern chinese postmenopausal women with early-stage breast cancer treated with different aromatase inhibitors: a retrospective study","volume":"7","author":"Tian","year":"2018","journal-title":"Clin Pharmacol Drug Dev"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/annonc\/mdq707","article-title":"The effect of exemestane, anastrozole, and tamoxifen on lipid profiles in Japanese postmenopausal early breast cancer patients: final results of National Surgical Adjuvant Study BC 04, the TEAM Japan sub-study","volume":"22","author":"Hozumi","year":"2011","journal-title":"Ann Oncol"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"R17-20230915","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1998","journal-title":"BMJ"},{"key":"R19-20230915","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"R20-20230915","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1002\/sim.3767","article-title":"Checking consistency in mixed treatment comparison meta-analysis","volume":"29","author":"Dias","year":"2010","journal-title":"Stat Med"},{"key":"R21-20230915","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J Clin Epidemiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018550","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T19:36:18Z","timestamp":1694806578000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000018550"}},"subtitle":["A protocol of systematic review"],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000018550","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}